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Abstract
Salmonella Typhi is the primary causative agent of typhoid fever; an acute systemic infec-
tion that leads to chronic carriage in 3–5% of individuals. Chronic carriers are asymptomatic,
difficult to treat and serve as reservoirs for typhoid outbreaks. Understanding the factors
that contribute to chronic carriage is key to development of novel therapies to effectively
resolve typhoid fever. Herein, although we observed no distinct clustering of chronic car-
riage isolates via phylogenetic analysis, we demonstrated that chronic isolates were pheno-
typically distinct from acute infection isolates. Chronic carriage isolates formed significantly
thicker biofilms with greater biomass that correlated with significantly higher relative levels
of extracellular DNA (eDNA) and DNABII proteins than biofilms formed by acute infection
isolates. Importantly, extracellular DNABII proteins include integration host factor (IHF) and
histone-like protein (HU) that are critical to the structural integrity of bacterial biofilms. In this
study, we demonstrated that the biofilm formed by a chronic carriage isolate in vitro, was
susceptible to disruption by a specific antibody against DNABII proteins, a successful first
step in the development of a therapeutic to resolve chronic carriage.
Author summary
Salmonella Typhi, a human restricted pathogen is the primary etiologic agent of typhoid
fever, an acute systemic infection that has a global incidence of 21 million cases annually.
Although the acute infection is resolved by antibiotics, 3–5% of individuals develop
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chronic carriage that is difficult to resolve with antibiotics. A majority of these indivuals
serve as reservoirs for further spread of the disease. Understanding the differences
between acute and chronic carrier strains is key to design novel targeted approaches to
undermine carriage. Here, we demonstrated that chronic carrier strains although not
genotypically distinct from acute strains, formed thicker biofilms with greater relative lev-
els of extracellular eDNA and DNABII proteins than those formed by acute infection iso-
lates. We also demonstrated that an antibody against DNABII proteins significantly
disrupted biofilms formed by a chronic carrier strain and therefore supported develop-
ment of therapeutic use of this antibody to attenuate chronic carriage.
Introduction
Salmonella enterica is a facultative intracellular, Gram-negative gammaproteobacterium,
which is classified into six subspecies that are further subtyped into more than 2000 serovars
or serotypes based on the expression of surface antigens [1,2]. In humans, S. enterica serovars
cause non-typhoidal [3] and typhoidal [4] illness that results in significant morbidity and mor-
tality worldwide. Non-typhoidal S. enterica causes gastroenteritis with a global burden of 93
million cases and 155,000 deaths annually [5]. Salmonella enterica serovar Typhi (S. Typhi) is a
human-restricted pathogen and the primary etiologic agent of typhoid fever with an incidence
of 21 million cases each year that results in 200,000 deaths annually [6].
Enteric or typhoid fever is an acute systemic infection that is commonly caused by poor
sanitation and the consumption of contaminated food or water [7]. Although acute infections
are resolved by treatment with antibiotics, a high incidence of antibiotic resistance with about
60% of strains that exhibit multidrug resistance, exacerbates the morbidity and mortality, par-
ticularly, within typhoid endemic regions [8]. Most importantly, 3–5% of the individuals with
an acute infection ultimately develop chronic asymptomatic carriage in the gallbladder [9].
This chronic carriage state not only serves as a reservoir for further spread of the disease via
bacterial shedding in feces, but is also difficult to resolve with antibiotics [10–13]. Given the
grave public health concern of both acute infections and chronic carriage of S. Typhi, it is
important to understand the development of each of these states to design and test targeted
approaches to resolve the more recalcitrant chronic carriage.
The hallmark of chronic carriage of S. Typhi is the successful colonization of the gallbladder
and biofilm formation on the surface of gallstones [14,15]. Biofilms are organized three-
dimensional multicellular communities encased in self-produced extracellular polymeric sub-
stances (EPS) that is comprised of polysaccharides, extracellular DNA [eDNA], proteins and
lipids [16,17]. Biofilm formation on the surface of gallstones is thought to protect the resident
bacteria from the harsh environment within the gallbladder (e.g. presence of bile), host
immune effectors, and antibiotics [18]. Although the negative impact of the chronic carriage
state on human health has been recognized for over a century, very little is known about the
genotypic and phenotypic differences between acute infection and chronic carriage isolates of
S. Typhi.
In order to better characterize the differences in phenotypic and genotypic characteristics
of acute infection and chronic carriage isolates of S. Typhi, in this study, we sequenced a lab
strain S. Typhi Ty2 (JSG698), and multiple acute infection (14 isolates from patients with an
acute infection) and chronic carriage isolates (6 isolates from chronic carriers). We also exam-
ined the ability of each of these isolates to form biofilms in vitro (as biofilm formation is a hall-
mark of chronic carriage) and compared the relative levels of multiple EPS components
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(eDNA, DNABII proteins and lipopolysaccharides [19,20]) within their respective biofilms to
determine if these correlated with differences in the magnitude of the biofilms formed. Per-
haps most importantly, we have also shown that S. Typhi biofilms, similar to those formed by
22 single and multi-species bacterial biofilms, incorporate DNABII proteins that stabilize the
eDNA lattice-like structure [21–24]. Sequestration of DNABII proteins from bacterial biofilm
via specific antibodies, results in collapse of the EPS which causes release of biofilm-resident
bacteria that are highly sensitive to antibiotics and immune factors [21,22,25–30].
In this study, we demonstrated that chronic carriage isolates formed thicker biofilms than
acute infection isolates and further, that of those components tested, the increase in biofilm
formation by chronic carriage isolates correlated only with greater steady state levels of eDNA
and DNABII proteins within the biofilm EPS. Overall, these data suggested that during car-
riage, chronic S. Typhi isolates may undergo pathoadaptation in the gallbladder for enhanced
biofilm capabilities. Indeed, we also demonstrated that we could disrupt biofilms formed by
chronic carriage isolates with a specific antibody that targets the DNABII proteins which
thereby supported development of therapeutic use of this antiserum to potentially attenuate
the chronic carriage of S. Typhi.
Results
Molecular and genetic typing of acute and chronic S. Typhi strains
To infer the phylogenetic relationship of acute and chronic S. Typhi isolates from Ohio,
Mexico City, and Vietnam (Table 1), we determined the whole-genome sequence using short
read sequence technology. A total of 1,777 single nucleotide polymorphisms in the core
genome with reference to S. Typhi Ty2 (AE014613) were used to construct a maximum-likeli-
hood phylogenetic tree (Fig 1A) in the context of 1909 global S. Typhi isolates reported previ-
ously [31]. The study isolates were widely distributed within the global diversity of S. Typhi
and ten isolates were of the H58 haplotype that constitute the currently dominant global pan-
demic clade [32]. Clinical isolates displayed high genetic similarity with multiple clades formed
(Fig 1B), with pairwise distance ranging from 1 to 548 SNPs in the core genome (Fig 1C).
However, there was no apparent clustering of the sequenced isolates by the acute versus
chronic infection status of the patient.
Chronic carrier isolates of S. Typhi formed thicker biofilms than acute
infection isolates
To identify any phenotypic alterations between S. Typhi strains isolated from acute and
chronic infections, we first set out to determine the differences in biofilms formed in vitro by
each of these strains. This is relevant as chronic carriage of S. Typhi is associated with biofilm
formation on the surface of gallstones [14,15]. We first characterized the differences in growth
of each of the S. Typhi strains and observed that the chronic carriage isolates (JSG3983 and
JSG3984) had a significantly longer doubling time than S. Typhi Ty2 strain JSG698 (S1 Fig
and Table 2). Of the these two strains only JSG3984 eventually matched the extent of growth
of S. Typhi Ty2 strain. Due to these two growth defects, JSG3983 was therefore the only strain
eliminated from our comparative analysis. Next, we allowed various S. Typhi chronic carriage
and acute infection isolates and the lab strains S. Typhi Ty2 (JSG698 and JSG4383) (Table 1)
to form biofilms in vitro. Since the lab strain S. Typhi Ty2 (JSG698) is deficient in rpoS, a
known regulator of stationary phase gene expression, an otherwise isogenic rpoS+ strain
(JSG4383 [33]) was also employed. First, no significant difference in biofilm formation
between the S. Typhi Ty2 (JSG698) and the S. Typhi Ty2 rpoS+ strain (JSG4383) was observed
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as evidenced by biofilm average thickness (Fig 2A) and biofilm biomass (Fig 2B). This result
suggested that the lack of rpoS had no significant effect on biofilm formation by the S. Typhi
Ty2 strain JSG698.
As shown in Fig 2, when grossly assessed, while 5 out of the 6 chronic carriage isolates
(83%) formed significantly thicker biofilms as compared to the lab strain S. Typhi Ty2
(JSG698), only 2 out of the 14 acute infection isolates (14%) formed significantly thicker bio-
films as compared to lab strain. Next, we determined the average thickness and biomass of bio-
films formed by chronic (indicated by the red dotted line labeled AC) versus and acute
infection isolates (indicated by the blue dotted line labeled AA). In general, chronic carriage
isolates formed significantly thicker biofilms (P<0.01) with greater biomass (P<0.01) com-
pared to those formed by acute infection isolates (Fig 2). To further validate our confocal
microscopy-based analyses, we enumerated the bacteria within each biofilm (adherent state)
and demonstrated that in biofilms formed by chronic carriage isolates, on average 52.5% of the
Table 1. Strains used in this study.
Laboratory strains
Strain Characteristics Source
JSG698 S. Typhi Ty2; wild-type ATCC
JSG4383 S. Typhi Ty2 rpoS+ [35]
JSG1213 S. Typhi Ty2 tviB::Kan Gift of Popoff lab, Pasteur Institute [34]
JSG210 S. Typhimurium 14028s; wild-type ATCC
Clinical Isolates
Strain Isolation source/characteristics Infection type Country of origin Source
JSG691 (ICOPHAI17078) Blood Acute USA University of Texas Health Science Center at San Antonio
JSG3074 (ICOPHAI17076) Gallstone Chronic Mexico General Hospital of Mexico, Mexico City
JSG4123 JSG3074 ΔtviB via Wanner NA NA This study
JSG3076 (ICOPHAI17077) Gallstone Chronic Mexico General Hospital of Mexico, Mexico City
JSG3395 (ICOPHAI17081) Blood Acute USA Ohio Department of Health
JSG3400 (ICOPHAI17086) Bile Acute USA Ohio Department of Health
JSG3407 (ICOPHAI17082) Stool Acute USA Ohio Department of Health
JSG3418 (ICOPHAI17085) Stool Acute USA Ohio Department of Health
JSG3419 (ICOPHAI17083) Blood Acute USA Ohio Department of Health
JSG3431 (ICOPHAI17084) Stool Acute USA Ohio Department of Health
JSG3433 (ICOPHAI17079) Blood Acute USA Ohio Department of Health
JSG3441 (ICOPHAI17080) Stool Acute USA Ohio Department of Health
JSG3979 (GB169) Gallbladder Chronic Vietnam Gift of S. Baker
JSG3980 (GB281) Gallbladder Chronic Vietnam Gift of S. Baker
JSG3981 (GB31) Gallbladder Chronic Vietnam Gift of S. Baker
JSG3982 (GB335) Gallbladder Chronic Vietnam Gift of S. Baker
JSG3983 (GB266) Gallbladder Chronic Vietnam Gift of S. Baker
JSG3984 (GB26) Gallbladder Chronic Vietnam Gift of S. Baker
JSG3985 (TY421) Unspecified Acute Vietnam Gift of S. Baker
JSG3986 (TY312) Unspecified Acute Vietnam Gift of S. Baker
JSG3987 (TY311) Unspecified Acute Vietnam Gift of S. Baker
JSG3988 (TY102) Unspecified Acute Vietnam Gift of S. Baker
JSG3989 (TY261) Unspecified Acute Vietnam Gift of S. Baker
JSG3990 (TY96) Unspecified Acute Vietnam Gift of S. Baker
NA = Not applicable.
https://doi.org/10.1371/journal.ppat.1009209.t001
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total bacteria were in the biofilm state, whereas this value was 26.8% for biofilms formed by
acute infection isolates (S2 Fig). These data were consistent with our analysis derived via con-
focal microscopy and collectively suggested that chronic carriage isolates were significantly dif-
ferent from acute infection isolates in their relative ability form biofilms, in vitro.
Chronic carriage isolates yielded higher steady state levels of eDNA and
DNABII proteins within their biofilm EPS compared to those formed by
acute infection isolates
Given that chronic carriage isolates formed a thicker biofilm with greater biomass as compared
to those formed by acute infection isolates, we examined the steady state levels of various EPS
components within S. Typhi biofilms to correlate with the differences in biofilm architecture
observed between chronic carriage and acute infection isolates. S. Typhi whole cells (WC;
extracellular) or cell lysates (Ly) were blotted on PVDF membranes and probed with either α-
Vi-antigen (S3A Fig) or α-O9 O-antigen of the LPS (S3B Fig) antibodies. As shown in S4 Fig,
Fig 1. Phylogenetic relationship of S. Typhi isolates. (A) Maximum likelihood phylogenetic tree based on core
genome sequence variation. This shows the relationship of S. Typhi strains used in this study in the context of a global
collection of S. Typhi strains reported in (31). (B) Maximum likelihood phylogenetic tree showing the relationship of
S. Typhi clinical isolates and S. Typhi Ty2 based on core genome sequence variation. (C) Single nucleotide
polymorphism distance matrix and heatmap of isolates in this study. There was no apparent clustering of the
sequenced isolates by the acute versus chronic infection status of the patient.
https://doi.org/10.1371/journal.ppat.1009209.g001
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while Vi-antigen was variably expressed by both chronic carriage and acute infection isolates,
no characteristic pattern of expression was observed for either group (S3A Fig). S. Typhimur-
ium strain 14028s and S. Typhi tviB::Kan [34] served as negative controls. O9 antigen was
below the level of detection in WC blots of multiple chronic carriage and acute infection iso-
lates. Additionally, no apparent difference in the expression of O9 antigen was observed
between chronic carriage and acute infection isolates (S3B Fig). S. Typhimurium strain 14028s
served as a negative control in these latter blots. These data suggested that chronic carriage iso-
lates had no discernible pattern of differences from acute infection isolates with respect to the
expression of either O9 antigen or Vi-antigen.
Next, we quantified the relative extracellular levels of eDNA and DNABII proteins within
the biofilms formed by the indicated S. Typhi strains. We allowed biofilms to be formed by
each strain for 40 hours, then incubated the biofilms with α-dsDNA monoclonal antibody and
α-IHFEc (recognizes both IHF and HU isolated from a large crossection of bacterial species;
also the primary amino acid sequences of IHF and HU from E. coli and Salmonella are identi-
cal) to visualize both eDNA and DNABII proteins within the biofilm EPS by immunofluores-
cence microscopy (IF). The bacterial membrane stain, FM 4–64 was used to designate the
overall biofilm architecture. The distribution of eDNA (teal) and DNABII proteins (purple)
within the biofilm EPS of representative chronic carriage (JSG3980) and acute infection
(JSG3986) isolates compared to lab strain S. Typhi Ty2 (JSG698) is shown in Fig 3A. The fluo-
rescence intensity of eDNA (Fig 3B) and DNABII proteins (Fig 3D) were quantified, and the
average fluorescence intensity of eDNA and DNABII proteins within the EPS of biofilms
Table 2. Doubling time in hours for each of the indicated S. Typhi strains.
Strain Doubling time (hours)
S. Typhi Ty2 (JSG698) 1.19 ± 0.01
JSG3395 1.14 ± 0.01
JSG3407 1.21 ± 0.01
JSG3418 1.20 ± 0.01
JSG3419 1.20 ± 0.01
JSG3431 1.23 ± 0.02
JSG3433 1.16 ± 0.02
JSG3441 1.17 ± 0.01
JSG3985 1.21 ± 0.004
JSG3986 1.24 ± 0.01
JSG3987 1.26 ± 0.01
JSG3988 1.24 ± 0.004
JSG3989 1.15 ± 0.01
JSG3990 1.20 ± 0.01
JSG3074 1.21 ± 0.005
JSG3979 1.20 ± 0.02
JSG3980 1.25 ± 0.02
JSG3981 1.19 ± 0.01
JSG3982 1.23 ± 0.01
JSG3983 1.36 ± 0.02 ����
JSG3984 1.33 ± 0.02 ����
Statistical significance of doubling times for each of the chronic carriage or acute infection strain versus the S. Typhi
Ty2 strain, JSG698 was assessed by a one-way ANOVA followed by Dunnett’s multiple comparison test.
����P<0.0001.
https://doi.org/10.1371/journal.ppat.1009209.t002
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formed by acute infection and chronic carriage isolates was represented by the blue and red
dotted lines labeled AA and AC respectively. As shown in Fig 3B and 3D, on average, chronic
carriage isolates had significantly higher steady state levels of both eDNA (P<0.01) and DNA-
BII proteins (P<0.01) within their biofilm EPS as compared to acute infection isolates. How-
ever, despite the greater absolute abundance of eDNA and DNABII proteins within biofilms
formed by chronic carriage isolates, the relative abundance of eDNA and DNABII proteins [as
determined by the ratio of fluorescence intensity of eDNA or DNABII proteins to the fluores-
cence intensity of bacteria] was not different (see dotted lines AC and AA in Fig 3C and 3E).
Thus, regardless of biofilm size, the ratio of eDNA and DNABII to the number of cells in
the biofilm remains constant. This result suggested that in order for biofilms to incorporate
bacterial cells they are rate limited by constant ratios of eDNA and DNABII i.e. the more
eDNA and DNABII present within the biofilms, the more bacteria they can incorporate. Col-
lectively, these data suggested that while chronic carriage and acute infection isolates did not
have a discernible difference in expression of either LPS or Vi-antigen, the relative amount of
eDNA and DNABII proteins were significantly greater within biofilms formed by chronic car-
riage isolates than that within the biofilms formed by acute infection isolates due to the pres-
ence of more bacteria.
Biofilms formed by S. Typhi were disrupted upon incubation with a
DNABII-specific antibody
DNABII proteins serve as linchpin proteins to stabilize the eDNA lattice structure and in turn,
sequestration of DNABII proteins from the biofilm EPS with specific antibodies results in sig-
nificant disruption of single and multi-species biofilms in vitro, ex vivo and in vivo [21,22,24–
27,29,30,35–37]. Accordingly, we hypothesized that the greater the steady state levels of DNA-
BII proteins present within a biofilm, the greater the dose of DNABII-directed antibodies that
would be required for biofilm disruption. Since biofilms formed by chronic carriage isolates
Fig 2. Chronic carriage isolates formed thicker biofilms than acute isolates. Biofilms of each of the indicated S.
Typhi strains were established in a 8-well chambered coverglass slide for 40 hours. Biofilms were stained with LIVE/
DEAD stain and visualized via CLSM. Images were analyzed by COMSTAT to calculate average thickness (A) and
biomass (B). Bars represent the standard error of the mean (SEM). The mean of the average thickness or biomass of
the chronic carriage isolates was represented by the red dotted line labeled AC and the mean of the average thickness
or biomass of the acute isolates was represented by the blue dotted line labeled AA. Statistical significance of average
thickness or biomass of each of the strains versus the the lab strain, S. Typhi Ty2 (JSG698), was assessed by a one-way
ANOVA followed by Dunnett’s multiple comparison test. Statistical significance between AC and AA were assessed by
a one-way ANOVA followed by Tukey’s multiple comparison test. �P<0.05, ��P<0.01, ���P<0.001, ����P<0.0001. On
average, chronic carriage isolates formed a thicker biofilm with more biomass than acute isolates. Chronic carriage
isolates are indicated in red and acute infection isolates are indicated in blue.
https://doi.org/10.1371/journal.ppat.1009209.g002
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had a greater amount of DNABII proteins, here we wanted to determine if these could none-
theless be disrupted with specific antibodies. To this end, we allowed the lab strain S. Typhi
Ty2 (JSG698) and the chronic carriage isolate (JSG3074; used here as a representative bacte-
rium) to form biofilms for 24 hours, then incubated these biofilms with α-IHFEc, for 16 hours.
Naive IgG was used as a negative control. As shown in Fig 4, biofilms formed by both the lab
strain and the chronic carriage isolate were significantly disrupted by α-IHFEc (significant
decrease in biomass as compared to naive IgG), although as hypothesized, a greater
Fig 3. Chronic carriage isolates have higher steady levels of extracellular DNA and DNABII proteins within their
biofilm EPS than acute isolates. Biofilms of each of the indicated S. Typhi strains were established in an 8-well
chambered coverglass slide for 40 hours. Biofilms were labeled with α-dsDNA monoclonal antibody, α-IHFEc and FM
4–64 and visualized via CLSM. (A) Representative immunofluorescence images of a lab wild type strain S. Typhi Ty2
(JSG698), chronic carriage isolate (JSG3980) and acute isolate (JSG3986). eDNA is visualized in teal and DNABII
proteins in purple. Images were analyzed by ImageJ to quantify the fluorescence intensity of eDNA (B), DNABII
proteins (D), and bacteria. Fluorescence intensity of eDNA and DNABII proteins were normalized to cells and plotted
in (C) and (E), respectively. Bars represent the SEM. AA and AC represent the averages of acute infection isolates and
chronic carriage isolates, respectively. Statistical significance between AC and AA were assessed by a one-way ANOVA
followed by Tukey’s multiple comparison test. ��P<0.01. On average, chronic carriage isolates had higher steady state
levels of both eDNA and DNABII proteins within the biofilm EPS as compared to acute isolates. Chronic carriage
isolates are indicated in red and acute infection isolates are indicated in blue.
https://doi.org/10.1371/journal.ppat.1009209.g003
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concentration of α-IHFEc was required to achieve a similar effect in the biofilm formed by the
chronic carriage isolate as that observed for the lab strain. This requirement for a greater con-
centration of α-IHFEc for biofilm disruption was consistent with the presence of higher steady
state levels of DNABII proteins within biofilm EPS of the chronic carriage isolate as compared
to the lab strain (Fig 3).
Since S. Typhi attaches to gallstones (that primarily consists of cholesterol) and encounters
bile in the gallbladder during establishment of a chronic carriage state, and that bile induces
biofilm formation of S. Typhi [15], we also determined the efficacy of biofilm disruption by α-
IHFEc in the presence of cholesterol or bile. Biofilms formed by S. Typhi Ty2 strain were dis-
rupted by α-IHFEc as observed by a significant reduction in biofilm biomass as compared to
naive IgG in the presence of either cholesterol (chambered coverglass slide was coated with
cholesterol to mimic the surface of gallstones) or 0.5% bile (Fig 4B and 4C). Although bile sig-
nificantly increased the biomass within the biofilms formed by the lab strain with a concomi-
tant increase in the expression of DNABII proteins both intracellularly (S4A Fig) as well as
that incorporated within the biofilm EPS (S4B and S4C Fig), a greater concentration of α-
IHFEc (500 μg/ml) nevertheless disrupted biofilms formed under conditions designed to
mimic those within the gallbladder. Collectively, these results suggested that the biofilms
formed by chronic carriage isolates were susceptible to disruption by α-IHFEc in vitro (albeit at
a higher α-IHFEc concentration), an essential first step to develop these antibodies as a thera-
peutic that can potentially resolve chronic carriage of S. Typhi.
Discussion
The chronic carriage state of S. Typhi is difficult to treat and these individuals also serve as res-
ervoirs that can cause community outbreaks of typhoid fever. A more comprehensive charac-
terization of the differences between acute infection and chronic carriage isolates is critical in
order to understand the development of the chronic carriage state and design novel, specific
targeted approaches to undermine carriage.
Fig 4. DNABII-specific antibody disrupted biofilms formed by chronic carriage isolate of S. Typhi. (A) Biofilms
formed by lab wild type strain S. Typhi Ty2 (JSG698) or chronic carriage isolate (JSG3074) or (B, C) JSG698 were
established in an 8-well chambered coverglass slide in TSB (A), chambered coverglass slide coated with 5 mg/ml
cholesterol (B), or TSB+0.5% ox bile extract (C) for 24 hours. Biofilms were incubated with medium alone, naive IgG,
or α-IHFEc IgG at the indicated concentration for 16 hours. Biofilms were stained with LIVE/DEAD stain and
visualized via CLSM. Images were analyzed by COMSTAT to calculate biomass. Bars represent the SEM. ��P<0.01,
���P<0.001 via unpaired t test. Biofilms formed by S. Typhi Ty2 (JSG698) in the presence of cholesterol and bile, as
well as a chronic carriage isolate of S. Typhi, were significantly disrupted by DNABII-specific antibody (α-IHFEc).
https://doi.org/10.1371/journal.ppat.1009209.g004
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In this study, we first characterized the genotypic and phenotypic differences between acute
infection and chronic carriage isolates of S. Typhi and demonstrated that each of these strains
were widely distributed within the global diversity of S. Typhi strains with no evident cluster-
ing. Although large-scale rearrangements between ribosomal RNA operons have been docu-
mented in longitudinal isolates of an S. Typhi strain from a chronic carrier [38], our sequence
analysis of multiple acute infection and chronic carriage isolates from various geographical
locations suggested no distinct clustering of strains based on the chronic carrier versus acute
infection status of the patient. Previous genome sequence comparison analysis of longitudinal
isolates of persistent S. Typhimurium revealed several SNPs in global virulence regulatory
genes such as rpoS, dksA, melR etc., that can cause pleiotropic changes in the transcription of
genes during persistence [39]. Also, acquisition of mobile genetic elements has been docu-
mented during persistence that is directly attributed to the antibiotic resistant phenotype of
chronic carriage isolates [38]. Thus, while in our study clustering of the acute infection versus
chronic isolates does not occur, genetic events do occur in the gallbladder environment that
likely affect strain phenotypes.
In contrast, we demonstrated that on average, chronic carriage isolates formed thicker bio-
films than acute isolates. This result is in line with previous findings which suggest that the
chronic carriage state of S. Typhi is facilitated by formation of biofilms on gallstones within
the gallbladder wherein S. Typhi predominantly persists [14,15]. Biofilm resident bacteria are
highly recalcitrant to antibiotic therapy, and clearance by host immune effectors (reviewed in
[40]), which in turn, facilitates chronic carriage. Much of this resistance is associated with the
EPS components within biofilms, which in addition to maintenance of the biofilm structure,
also provides a physical barrier to and directly compromises the activities of host immune
effectors [16]. eDNA is a key structural component of bacterial biofilms [41–44] and is also
incorporated within S. Typhimurium biofilms wherein it facilitates resistance to antibiotics
and antimicrobial peptides [45]. In this study, we have shown that the thicker biofilms of
chronic carriage isolates correlated with a greater relative level of eDNA than acute infection
isolates that could also likely contribute to their recalcitrance to treatment modalities.
Previous studies have identified several S. Typhi uniquely expressed antigens from chronic
carrier sera that include membrane proteins, lipoproteins and hemolysin-related proteins [46].
Additionally, persistent/chronic carriage isolates of S. Typhi exhibit increased expression of
iron transporters and other factors that provide resistance to host antimicrobial peptides [47].
We have now identified DNABII proteins to be differentially and highly expressed within the
EPS of the biofilms formed by chronic carriage isolates of S. Typhi. Whereas the role of this
increased steady state level of eDNA and DNABII proteins, beyond their contribution to bio-
film structural integrity is not yet known, a DNABII member expressed by Mycobacteria is
known to possess ferroxidase activity. It has been suggested that ferrous iron (used for fenton
chemistry to generate peroxide as a host defense) could be de-toxified by released DNABII
protein-mediated oxidation to the ferric state, suitable for bacterial iron transport and utiliza-
tion [48]. In addition, environmental factors such as bile within the gallbladder upregulate the
expression of EPS components [49,50] that are required for biofilm formation on gallstones
[20,51,52]. In line with these findings, herein we also observed that bile upregulated the intra-
cellular expression of DNABII proteins which corresponded with a concomitant increased
incorporation of these proteins into the biofilm EPS. Furthermore, the DNABII protein IHF
positively regulates the expression of curli, another EPS component that contributes to biofilm
formation by S. Typhi [53]. Collectively, our new data contribute to the findings of others to
suggest that the microenvironment wherein S. Typhi persists results in positive regulation of
components (proteins, polysaccharides etc.,) that promote the chronic carriage state.
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The DNABII family of proteins are highly conserved and one of the members of the family,
HU is ubiquitously expressed by eubacteria. DNABII proteins bind to and bend DNA [54,55]
and thereby play a critical role in the intracellular nucleoid structure and function [56]. These
proteins are also found in the EPS of multiple single and multi-species bacterial biofilms [21–
24,27,30,35,57]. In this study, we now expanded upon our previous observations to demonstrate
that extracellular DNABII proteins were incorporated within the EPS of biofilms formed by
both acute infection and chronic carriage isolates of S. Typhi and that these proteins are critical
to the structural integrity of biofilms formed by S. Typhi. These data are in line with our previ-
ous findings that DNABII proteins serve as linchpin proteins to stabilize the eDNA lattice struc-
ture and their sequestration, via incubation with a specific antibody, disrupts multiple bacterial
biofilms in vitro [21,22,24,26,27,29,36], resolves bacterial biofilms in vivo [27,30,37], and dis-
solves sputum solids ex vivo [35]. Moreover, pre-incubation with the aforementioned DNABII-
specific antibody reduces binding of uropathogenic E. coli to cultured bladder epithelial cells
[58] and also, reduces survival of Burkholderia cenocepacia that have been phagocytized by
murine cystic fibrosis macrophages [22]. Collectively, these results indicate that the extracellular
presence of the DNABII family of proteins is involved in facets of pathogenesis in addition to its
structural role in the EPS. Finally, here for the first time, we demonstrated that for multiple iso-
lates of S. Typhi, there was a constant ratio between cells, eDNA and DNABII regardless of bio-
film size. This latter finding strongly implied that eDNA and DNABII proteins, and their
associated specific ratios, were rate limiting for biofilm formation and further suggested that
more eDNA and DNABII within the biofilm matrix can shift the partitioning of cells from the
planktonic state into the adherent biofilm state. Should this paradigm exist throughout eubacte-
rial biofilms, it would indicate that the most likely rationale is for there to be a uniform common
eDNA-DNABII-dependent EPS that exists within the biofilms formed by diverse species. Given
that the DNABII proteins are universally conserved and have been well documented to stabilize
bacterial biofilm structure, the ability to significantly disrupt a biofilm formed by a chronic car-
riage isolate with antibody directed against a DNABII protein is an exciting first step in the
development of a novel therapeutic to attenuate chronic carriage of S. Typhi.
Materials and methods
Bacterial strains and growth conditions
Bacterial strains used in this study are listed in Table 1. All clinical S. Typhi isolates tested posi-
tive by Vi-antigen agglutination test before use. Strains were streaked on lysogeny broth (LB)
agar plates and incubated at 37˚C for 18–20 hours. Single colonies were used to start overnight
(O/N) liquid cultures. Planktonic cells were grown at 37˚C on a rotating drum in LB or tryptic
soy broth (TSB). Antibiotics, when needed, were used at the following concentrations: chlor-
amphenicol, 25 μg/ml; ampicillin, 50 or 100 μg/ml, kanamycin, 45 μg/ml; and streptomycin,
100 μg/ml. The deletion of tviB in strain JSG3074 was generated by the λ-Red mutagenesis
method [59] with the following primers: upstream primer JG2934 (5’-ataaaattttagtaaaggattaa-
taagagtgttcggtatagtgtaggctggagctgcttc– 3’), downstream primer JG2935 (5’–gtccgtagttcttcg-
taagccgtcatgattacaatctcaccatatgaatatcctccttag– 3’), and verified with primers JG2936 (5’-
tcagcgacttctgttctattcaagtaagaaaggggtacgg– 3’), and JG2937 (5’ -gctcctcactgacggacgtgc-
gaacgtcgtctagattatg- 3’). Antibiotic resistance markers were swapped out using pCP20 [60].
The mutant was verified via sequencing.
Molecular and genetic typing of acute and chronic S. Typhi strains
Clinical S. Typhi strains acquired from Vietnam had been previously whole-genome
sequenced before use in this study. All remaining isolates were whole-genome sequenced as
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part of a consortium with the U.S. Food and Drug Administration (FDA). Genomic DNA of
each strain was isolated from overnight cultures using DNeasy Blood and Tissue kit (Qiagen,
CA, United States). Isolates were sequenced using Illumina’s MiSeq platform (Illumina, Inc.,
CA, United States). Sample preparation and the sequencing library was prepared using the
Nextera XT Sample Preparation Kit and then sequenced for 2 × 250 cycles. The assembled
sequences were annotated using the NCBI Prokaryotic Genomes Annotation Pipeline (PGAP)
and have been deposited at DDBJ/EMBL/GenBank. Genomes are publicly available from Path-
ogen Detection at NCBI (search ICOPHAI IDs at https://www.ncbi.nlm.nih.gov/pathogens/
isolates/).
The maximum-likelihood phylogenetic tree was constructed from the core SNP alignment
of all isolates using snippy version 3.0 as previously described [61]. S. Typhi Ty 2 (JSG698) was
used as a reference for the mapping and SNP calling steps. S. Paratyphi A (strain A270) and S.
Typhimurium 14028s (JSG210) where included as outgroups to infer the true root for the tree
in Fig 1A and 1B respectively, but were removed for mapping and variant calling and the
resulting tree manually rooted. RAxML (version 8.2.10) [62] was used to construct maximum
likelihood phylogenetic trees from the core SNP alignment, with the generalized time-revers-
ible model and a Gamma distribution to model site-specific rate variation (the GTR+Γ substi-
tution model; GTRGAMMA in RAxML). Support for the maximum-likelihood phylogeny was
assessed via 400 rapid bootstraps based on the MRE_IGN-based Bootstrapping criterion.
Visualization and quantification of biofilms formed by various S. Typhi
strains
S. Typhi strains were cultured on TSB agar for 18–20 h at 37˚C, 5% CO2 in a humidified atmo-
sphere, then suspended in TSB to an OD of 0.65 at 490 nm. Cultures were diluted 1:6 in TSB,
then incubated statically at 37˚C, 5% CO2 until an OD of 0.6 was reached at 490 nm. The cul-
tures were diluted 1:2500 in TSB and 200 μl of this suspension was inoculated into each well of
an eight-well chambered cover glass slide (Fisher Scientific). Slides were incubated statically
for 16 h at 37˚C, 5% CO2 in a humidified atmosphere at which time, spent medium was aspi-
rated and replaced with fresh TSB. After an additional 8 h (24 h total incubation time), spent
medium was aspirated and replaced with fresh TSB. After an additional 16 h (40 h total incu-
bation time), biofilms were stained with LIVE/DEAD BacLight Bacterial Viability kit for
microscopy (Molecular Probes) as per manufacturer’s instructions, then fixed (1.6% parafor-
maldehyde- 0.025% glutaraldehyde, 4% acetic acid in 0.2M phosphate buffer, pH 7.4). Biofilms
were visualized via Zeiss 510 Meta-laser scanning confocal microscope and imaged with a x63
objective. Biofilm average thickness and biomass were determined by COMSTAT analysis
[63]. The assay was repeated three times on separate days. Data are presented as mean ± SEM.
Determination of the number of bacteria in the planktonic or biofilm state
Biofilms were established as described in ‘Visualization and quantification of biofilms’ for 40
h. Bacteria within the adherent biofilm as well as those within the culture fluid above the bio-
film (e.g. planktonic state) were enumerated as described previously [57].
Dot blot assay
Bacterial cultures were grown overnight in TSB at 37˚C with aeration, fixed in 4% paraformal-
dehyde (PFA), and normalized to OD600 = 0.8 in PBS. Normalized cultures were then divided
into a lysate group and a non-lysate group (no further processing). Lysate group was boiled for
10 min to lyse the cells. Bacterial dilutions (1:6 for Vi-antigen; 1:20 and 1:50 for O9 antigen)
were prepared, and 200 μl was spotted onto methanol-activated PVDF membranes using a
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suction manifold device. The blots were dried and blocked at 4˚C O/N with 5% milk buffer,
followed by incubation in either α-Vi-antigen (1:1000) or α–O9 antigen (1:1000). The blots
were washed 3 times, 15 minutes each, in tris-buffered saline with polysorbate 20 (TBST) and
incubated with α-mouse IgG 1:2000 (for O9 antigen) or α- rabbit IgG 1:2000 (for Vi Antigen)
antibodies conjugated with horseradish peroxidase (Bio- Rad) O/N at 4˚C prior to visualiza-
tion using the Bio-Rad Chemi-Doc XRS system.
Visualization and quantification of eDNA and DNABII proteins within the
biofilm EPS of various S. Typhi strains
Biofilms were established as described in ‘Visualization and quantification of biofilms’ for 40
h. Unfixed biofilms were washed once with sterile PBS and incubated with either: 5 μg/ml
mouse isotype control IgG 2a; 5 μg/ml α-dsDNA monoclonal antibody; 7.5 μg/ml naive rabbit
IgG; or 7.5 μg/ml α-IHFEc in 5% BSA in PBS for 1 h at room temperature. Biofilms were
washed once with PBS and incubated with 1:200 dilution of each of goat α-mouse IgG 405,
goat α-rabbit IgG 488 and FM4-64 for 1 h at room temperature. Biofilms were washed once
with PBS then imaged with a x63 objective on a Zeiss 800 Meta-laser scanning confocal micro-
scope (Zeiss). Three-dimensional images were reconstructed with AxioVision Rel 4.8 (Zeiss).
Fluorescence intensity of DNABII proteins, eDNA and bacteria were quantified by ImageJ
software and relative abundance of eDNA or DNABII proteins were determined by the ratio
of fluorescence intensity of eDNA or DNABII proteins to the fluorescence intensity of bacteria.
The assay was repeated three times on separate days. Bars represent the mean ± SEM.
Disruption of S. Typhi biofilms with α-IHFEC
S. Typhi strains were cultured on TSB agar for 18–20 h at 37˚C, 5% CO2 in a humidified atmo-
sphere, then suspended in TSB to an OD of 0.65 at 490 nm. Cultures were diluted 1:6 in TSB
then incubated statically at 37˚C, 5% CO2 until an OD of 0.6 was reached at 490 nm. The cul-
tures were diluted1:2500 in TSB or TSB supplemented with ox bile extract or human bile to
0.5%, and 200 μl of this suspension was inoculated into each well of an eight-well chambered
cover glass slide. Slides were coated with cholesterol as described [50]. Slides were incubated
statically for 16 h at 37˚C, 5% CO2 in a humidified atmosphere at which time, spent medium
was aspirated and replaced with fresh TSB. After an additional 8 h (24 h total incubation time),
the spent medium was aspirated and replaced with fresh TSB or TSB that contained either
naive IgG or α-IHFEc IgG (150 μg/ml– 500 μg/ml). Slides were incubated statically for 16 h at
37˚C, 5% CO2 in a humidified atmosphere. Biofilms were stained and imaged as described in
‘Visualization and quantification of biofilms’.
Supporting information
S1 Fig. Characterization of planktonic growth of various S. Typhi strains. Exponential
phase cultures of each of the indicated strains was diluted 1:1000 in TSB and incubated at 37˚C
with continuous shaking. Absorbance at 490 nm were measured every 15 min for 16 hours.
(A) Growth curve plot of chronic carriage isolates versus the lab wild type strain S. Typhi Ty2
(JSG698), in triplicates. (B) Growth curve plot of acute isolates versus the S. Typhi Ty2 strain
(JSG698), in triplicate. JSG3983 and JSG3984 were the only strains wherein a defect growth
rate was observed. JSG3983 also did not grow to the same extent as S. Typhi Ty2 strain
(JSG698).
(TIF)
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S2 Fig. Enumeration of bacteria within biofilms formed by various S. Typhi strains. Bio-
films of each of the indicated S. Typhi strains were established on a 8-well chambered cover-
glass slide for 40 hours. Biofilms were washed twice in sterile PBS, suspended in PBS, and
enumerated on TSB agar. Of the total bacteria within the chambered coverglass, those that
were adherent within the biofilm were enumerated and values presented as percent of total.
Bars represent the SEM. The mean of the percent biofilm bacteria of the chronic carriage iso-
lates was represented by the dotted line labeled AC and the mean of the percent biofilm bacte-
ria of the acute infection isolates was represented by the dotted line labeled AA. Statistical
significance of average thickness or biomass of each of the strains versus the S. Typhi Ty2
strain, JSG698 was assessed by a one-way ANOVA followed by Dunnett’s multiple comparison
test. Statistical significance between AC and AA were assessed by a one-way ANOVA followed
by Tukey’s multiple comparison test. �P<0.05, ��P<0.01, ���P<0.001, ����P<0.0001. On aver-
age, chronic carriage isolates had more bacteria within their biofilms than acute isolates.
Chronic carriage isolates are indicated in red and acute infection isolates are indicated in blue.
(TIF)
S3 Fig. Expression profile of Vi antigen and O9 antigen in various S. Typhi strains. Repre-
sentative images of dot blots for expression of Vi antigen (A) and LPS (B). Either whole cells
(WC) or cell lysates (Ly) of each of the indicated strains were spotted on methanol-activated
PVDF membranes using a suction manifold device. The blots were probed with α-Vi antigen
antibody (A) or α- O9 antigen antibody (B). No clear differences in the expression of Vi anti-
gen or O9 antigen were observed between chronic carriage isolates and acute isolates.
(TIF)
S4 Fig. Bile increased the expression of DNABII proteins intracellularly and increased the
incorporation of DNABII proteins extracellularly within the biofilm EPS. (A) Planktoni-
cally grown S. Typhi Ty2 (JSG698) was pelleted, lysed and proteins were resolved on an
SDS-PAGE gel. DNABII proteins were quantified by Western blot. (B) S. Typhi Ty2 (JSG698)
biofilms were formed in vitro in the presence of TSB or TSB + 0.5% ox bile extract for 40
hours. Biofilms were labeled with α-IHFEc and FM 4–64 and visualized via CLSM. Representa-
tive immunofluorescence images that show the distribution of DNABII proteins within the
biofilms. Images were analyzed by ImageJ to quantify the fluorescence intensity of DNABII
proteins and bacteria. Fluorescence intensity of DNABII proteins (C) and fluorescence inten-
sity of DNABII proteins normalized to cells (D) were plotted. Bars represent the SEM.
�P<0.05, ��P<0.01 via unpaired t test. Bile increased the intracellular and extracellular steady
state levels of DNABII proteins within S. Typhi biofilms.
(TIF)
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